Lupin Launches Generic Safyral Tablets In The Us
Pharma major Lupin has announced the launch of its Tydemy Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3 mg/0.03 mg/0.451 mg and Levomefolate Calcium, 0.451 mg) having received an approval from the USFDA earlier. The drug is the generic equivalent of Bayer HealthCare Pharmaceuticals Inc.’s Safyral tablets, which are indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception. It had annual sales of approximately $22-mn in the US.
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
Chevron Opens Oilfield Chemical Technology to Rivals
-
Domo Chemicals’ Triple Collapse: As Chinese Low-Cost Capacity Meets Europe’s Energy Wall, the First Crack Appears in the Continent’s Chemical Empire
-
NOVA Chemicals Launches PE Resins with Next-Generation Non-Fluoropolymer Processing Aid
-
Sherwin-Williams Surpasses $100 Billion in Market Cap: Is This the ‘Apple Moment’ for Paint, or America’s Industrial ‘One Hundred Years of Solitude’?
-
The Carbon Tollbooth Is Open: EU’s CBAM Ushers in a New Era of Climate-Linked Trade
-
Carbon Fiber’s Price Surge Signals a New Era of Strategic Value—and Supply Tension
-
Clean Food Group Secures UK, EU, and US Approval for Fermentation-Derived Cosmetic Oils
-
EU Greenlights Four GM Crops—But Only at the Border
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
Recommend Reading
-
Stahl Reopens Ranipet Plant
-
Why Did Chemical Raw Materials Unexpectedly Escape the Latest Round of U.S. 301 Tariffs on 60 Economies?
-
Keshun Enters Industrial Coatings: Waterproofing Leader Seeks Growth Beyond Real Estate
-
Iran's Only MDI/TDI Plant Attacked, Middle East Supply Nearly Zero, Global Gap Widens
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
Both Cost and Demand Weaken, PTA Prices Remain Stagnant and Consolidate
-
September Adipic Acid Market Fluctuates and Declines
-
Palm Oil Market in November Experiences Volatile Decline
-
Phosphate Market Prices Slightly Decline (9.22-9.26)
-
Aniline Market Sees Slight Increase This Week (9.22–9.26)